CClassifation of CannabisPublic classificationby Justin Strekal, NORML Political Director
October 16, 2018
Comments
The US Food and Drug Administration is seeking public comments specific to whether changes ought to be recommended regarding the international classification of cannabis as a controlled substance. Members of the public have until October 31, 2018 to submit their comments to the FDA for consideration.
The FDA says that the comments “will be considered in preparing a response from the United States to the World Health Organization regarding the abuse liability and diversion” of marijuana and certain other substances.
In April, in response to a similar FDA request, NORML collected and hand-delivered over 10,000 comments to the agency calling on it to recommend a lifting of international restrictions criminalizing the plant. In total, comments from NORML members totaled over 60% of the public comments submitted nationwide.
Click here to submit a public comment NOW
In NORML’s latest comments to the FDA, it opined that “cannabis be removed from the international drug conventions so that nations that wish to do so may further expand their regulations governing cannabis’ use, possession, production, and dispensing for either recreational or medical use.”
Let’s continue to dominate the debate. Click here to submit your own public comment now.
Then take the next step:
Share our Action Alert on Twitter
Share our Action Alert on Facebook
Posted in : ACTIVISM, Advocacy, Citizen Lobbyists, GOVERNMENT, Policy
Add Your Comment
Do your part to
help legalize marijuana! (how?)
Act!
Donate
Lawyers
Shop
NORML Newsletter
FDA Seeks Public Comments Regarding International Classification Of Cannabis
October 17, 2018
CClassifation of CannabisPublic classificationby Justin Strekal, NORML Political Director
October 16, 2018
Comments
The US Food and Drug Administration is seeking public comments specific to whether changes ought to be recommended regarding the international classification of cannabis as a controlled substance. Members of the public have until October 31, 2018 to submit their comments to the FDA for consideration.
The FDA says that the comments “will be considered in preparing a response from the United States to the World Health Organization regarding the abuse liability and diversion” of marijuana and certain other substances.
In April, in response to a similar FDA request, NORML collected and hand-delivered over 10,000 comments to the agency calling on it to recommend a lifting of international restrictions criminalizing the plant. In total, comments from NORML members totaled over 60% of the public comments submitted nationwide.
Click here to submit a public comment NOW
In NORML’s latest comments to the FDA, it opined that “cannabis be removed from the international drug conventions so that nations that wish to do so may further expand their regulations governing cannabis’ use, possession, production, and dispensing for either recreational or medical use.”
Let’s continue to dominate the debate. Click here to submit your own public comment now.
Then take the next step:
Share our Action Alert on Twitter
Share our Action Alert on Facebook
Posted in : ACTIVISM, Advocacy, Citizen Lobbyists, GOVERNMENT, Policy
Add Your Comment
Do your part to
help legalize marijuana! (how?)
Act!
Donate
Lawyers
Shop
NORML Newsletter
Search
RECENT PRESS RELEASES
The Changing Landscape Of Clean Energy After The Recent Election
SWI Editorial StaffNovember 25, 2024|
Asian Development Banks signs deals with the Solomon Islands and Tonga to bolster Pacific solar PV
SWI Editorial StaffNovember 25, 2024|
Sony Ventures Looks to Quantum and Renewable Energy for Scalable Deep Tech Investments
SWI Editorial StaffNovember 25, 2024|
Masdar and Silk Road sign MoU for renewables in BRI countries
SWI Editorial StaffNovember 25, 2024|
‘Yellowstone’: This Season’s Most Shocking Drama? Watching Creator Taylor Sheridan Tear Down Kevin Costner’s Legacy
SWI Editorial StaffNovember 25, 2024|
Yellowstone star Dawn Olivieri on that shocking ending, how betrayal of Kevin Costner’s character hastened show’s end
SWI Editorial StaffNovember 25, 2024|
Related Post
Unlock Your Trading Potential
StockWatchIndex Trading Insights – A Six-Part Series of SWI White Papers
Infused beverages lead Election Day marijuana product sales spike
Nvidia Stock Is a Top Pick for November, According to 1 Wall Street Analyst